May 1991
Volume 32, Issue 6
Free
Articles  |   May 1991
Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.
Author Affiliations
  • M A Howard
    David G. Cogan Eye Pathology Laboratory, Howe Laboratory, Harvard Medical School/Massachusetts Eye and Ear Infirmary, Boston 02114.
  • S Wardwell
    David G. Cogan Eye Pathology Laboratory, Howe Laboratory, Harvard Medical School/Massachusetts Eye and Ear Infirmary, Boston 02114.
  • D M Albert
    David G. Cogan Eye Pathology Laboratory, Howe Laboratory, Harvard Medical School/Massachusetts Eye and Ear Infirmary, Boston 02114.
Investigative Ophthalmology & Visual Science May 1991, Vol.32, 1711-1713. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M A Howard, S Wardwell, D M Albert; Effect of butyrate and corticosteroids on retinoblastoma in vitro and in vivo.. Invest. Ophthalmol. Vis. Sci. 1991;32(6):1711-1713.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

The effect of sodium butyrate (NaB) alone and in combination with a glucocorticoid was studied on Y-79 retinoblastoma cells both in vitro and in vivo. Both NaB (0.5 and 4 mM) and hydrocortisone (1-100 microM) added separately to cells grown in suspension resulted in a small growth inhibition (less than 15%). A marked synergistic effect (75-77% growth inhibition) was observed in vitro when NaB and hydrocortisone were added in combination at all the concentrations tested. With in vivo experiments using the nude mouse model of retinoblastoma, the combination of NaB and methylprednisolone did not inhibit tumor growth.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×